High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update

scientific article published on 01 December 1993

High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/OXFORDJOURNALS.ANNONC.A058399
P698PubMed publication ID7509620

P2093author name stringG Bonadonna
S Siena
A M Gianni
P Valagussa
M Bregni
M Di Nicola
F Lombardi
M Magni
F Peccatori
L Gandola
P433issue10
P304page(s)889-891
P577publication date1993-12-01
P1433published inAnnals of OncologyQ326122
P1476titleHigh-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update
P478volume4

Reverse relations

cites work (P2860)
Q44866798Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease
Q37404397Anti-Müllerian hormone and antral follicle count reveal a late impairment of ovarian reserve in patients undergoing low-gonadotoxic regimens for hematological malignancies
Q44048384Autologous stem cell transplantation for Hodgkin's disease: busulfan, melphalan and thiotepa compared to a radiation-based regimen
Q33947871Current treatment of Hodgkin's disease
Q36135255Dietary factors and the risk of endometrial cancer: a case--control study in Greece
Q42848151Dose Intensity of Chemotherapy in Patients With Relapsed Hodgkin's Lymphoma
Q73086630Early total white blood cell recovery is a predictor of low number of apheresis and good CD34(+) cell yield
Q36135259High-dose chemotherapy and autologous bone marrow transplant in relapsed Hodgkin's disease--a pragmatic prognostic index
Q44454008High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in pat
Q71571874High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failure and survival
Q77635506Hodgkin's disease
Q31521042Idarubicinol myelotoxicity: a comparison of in vitro data with clinical outcome in patients treated with high-dose idarubicin
Q44177895Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin's disease (Croatian experience).
Q72054549Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease
Q80990535Stem-cell transplant for Hodgkin's lymphoma: does choice of therapy prior to high-dose treatment matter?
Q78027899The high-dose sequential (Milan) chemotherapy/PBSC transplantation regimen for patients with lymphoma is not cardiotoxic

Search more.